| __timestamp | Grifols, S.A. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 1271353000 |
| Thursday, January 1, 2015 | 224193000 | 1620577000 |
| Friday, January 1, 2016 | 197617000 | 2052295000 |
| Sunday, January 1, 2017 | 288320000 | 2075142000 |
| Monday, January 1, 2018 | 240661000 | 2186100000 |
| Tuesday, January 1, 2019 | 276018000 | 3036600000 |
| Wednesday, January 1, 2020 | 294216000 | 2735000000 |
| Friday, January 1, 2021 | 354881000 | 2908100000 |
| Saturday, January 1, 2022 | 361140000 | 3592500000 |
| Sunday, January 1, 2023 | 330551000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, innovation is key to staying ahead. Regeneron Pharmaceuticals, Inc. and Grifols, S.A. are two giants in the industry, each with a distinct approach to research and development (R&D) spending. Over the past decade, Regeneron has consistently outpaced Grifols in R&D investment, with a staggering 1,200% more spending in 2023 compared to Grifols. This trend highlights Regeneron's commitment to innovation, as their R&D expenses have grown from approximately $1.3 billion in 2014 to over $4.4 billion in 2023. Meanwhile, Grifols has shown a steady increase, with R&D spending rising by 83% over the same period. This data underscores the strategic priorities of these companies, with Regeneron focusing heavily on pioneering advancements, while Grifols maintains a more conservative yet consistent investment in innovation.
Revenue Insights: Regeneron Pharmaceuticals, Inc. and Grifols, S.A. Performance Compared
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Grifols, S.A. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Grifols, S.A. vs Dynavax Technologies Corporation
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and Novavax, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Evotec SE